3,5-Dichloro-4-nitropyridine, 95.0%, 10g

Lithium phenyl(2,4,6-trimethylbenzoyl)phosphinate, 97%, 1g

METHYL 8-AMINO-5,6,7,8-TETRAHYDRONAPHTHALENE-2-CARBOXYLATE HCL, 95.0%, 100mg

N-(4-Chlorobenzyl)cyclopentanamine, 97%, 5g

Toluene-3,4-dithiol>97.0%(GC)(T)25g

NONACOSAN-15-YLBENZENE, 95%, 1g

(4-Chloro-5-methyl-pyrimidin-2-yl)-cyclopropyl-amine, 95.0%, 250mg

2-(2,4-Dichlorophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95.0%, 25g

2-(4-Methoxy-phenyl)-5-methyl-2H-pyrazol-3-ylamine, 95.0%, 1g

Sodium deuterium oxide, 30% solution in D2O, 99.5 at%D, 10 ml, glass packaging

(Z)-Methyl 3-(((4-(methylamino)phenyl)amino)(phenyl)methylene)-2-oxoindoline-6-carboxylate (Nintedanib Impurity), 97%, 50mg

(R)-2-Methoxymethylpyrrolidine hydrochloride, 97.0%, 5g

Methyl propionylacetate, 98.0%, 25g